Oestrogen replacement therapy and coronary heart disease

References

• Stampfer M J, Colditz G A. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin S M, Petitti D B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37
   PubMed Web of Science ®Google Scholar
• Sullivan J M, Fowlkes L P. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol 1996; 87(2 Suppl)36S–43S
   Web of Science ®Google Scholar
• Tikkanen M J. Cardiovascular effects of estrogen therapy (in Finnish). Duodecim 1996; 112: 1089–95
   PubMedGoogle Scholar
• Sullivan J M, Zwaag R V, Lemp G F, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108: 358–63
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer M J, Manson J E, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61
   PubMed Web of Science ®Google Scholar
• Ettinger B, Friedman G D, Bush T, Quesenberry C P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87: 6–12
   PubMed Web of Science ®Google Scholar
• Cauley J A, Seeley D G, Browner W S, et al. Estrogen replacement therapy and mortality among older women. Arch Intern Med 1997; 157: 2181–7
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer M J, Colditz G A, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769–75
   PubMed Web of Science ®Google Scholar
• Brinton L A, Schairer C. Postmenopausal hormone-replacement therapy - time for a reappraisal?. N Engl J Med 1997; 336: 1821–2
   PubMed Web of Science ®Google Scholar
• Falkeborn M, Persson I, Adami H, et al. The risk of acute myocardial infarction after oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821–8
   PubMedGoogle Scholar
• Psaty B M, Heckbert S R, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogen and progestins in postmenopausal women. Arch Intern Med 1994; 154: 1333–9
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199–208
   PubMed Web of Science ®Google Scholar
• Tønnes Pedersen A, Lidegaard Ø, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997; 350: 1277–83
   PubMed Web of Science ®Google Scholar
• Falkeborn M, Persson S, Terént A, Adami H-O, Lithell H, Bergström R. Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993; 153: 1201–9
   PubMed Web of Science ®Google Scholar
• Finucane F F, Madans J H, Bush T L, Wolf P H, Kleinman J C. Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med 1993; 153: 73–9
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115: 455–6
   PubMed Web of Science ®Google Scholar
• Matthews K A, Kuller L H, Wing R R, et al. Prior to estrogen replacement therapy, are users healthier than nonusers?. Am J Epidemiol 1996; 143: 971–8
   PubMed Web of Science ®Google Scholar
• Cauley J A, Cummings S R, Black D M, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990; 163: 1438–44
   PubMed Web of Science ®Google Scholar
• Grodstein F. Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy?. Am J Epidemiol 1996; 143: 979–82
   PubMed Web of Science ®Google Scholar
• Sacks F M, Walsh B W. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci 1990; 592: 272–85
   PubMed Web of Science ®Google Scholar
• Krauss R M. Lipids and lipoproteins and effects of hormone replacement. Treatment of the Postmenopausal Women: Basic and Clinicals Aspects, R A Lobo. Raven Press, New York 1994; 235–42
   Google Scholar
• Sacks F M, Walsh B W. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 1994; 5: 236–40
   PubMedGoogle Scholar
• Campos H, Walsh B W, Judge H, Sacks F M. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997; 82: 3955–63
   PubMed Web of Science ®Google Scholar
• Tilly-Kiesi M, Lappi M, Puolakka J, Luotola H, Pyörälä T, Taskinen M-R. Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses. Eur J Clin Invest 1996; 26: 1125–33
   PubMed Web of Science ®Google Scholar
• Wagner J D, Schwenke D C, Zhang L, Applebaum-Bowden D, Bagdade J D, Adams M R. Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomolgus monkeys. Arterioscler Thromb Vase Biol 1997; 17: 1128–34
   PubMed Web of Science ®Google Scholar
• Walsh B W, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks F M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196–204
   PubMed Web of Science ®Google Scholar
• Knapp R H, Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 1997; 82: 3952–4
   PubMed Web of Science ®Google Scholar
• Walsh B W, Li H, Sacks F M. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 1994; 35: 2083–93
   PubMed Web of Science ®Google Scholar
• Brinton E A. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vase Biol 1996; 16: 431–40
   PubMed Web of Science ®Google Scholar
• Tikkanen M J, Nikkilä E A, Kuusi T, Sipinen S. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 1982; 54: 1113–7
   PubMed Web of Science ®Google Scholar
• Applebaum-Bowden D, McLean P, Steinmetz A, et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. Lipid Res 1989; 30: 1895–906
   PubMed Web of Science ®Google Scholar
• Taskinen M-R, Kuusi T. Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab 1987; 1: 639–66
   PubMed Web of Science ®Google Scholar
• Archer T K, Tarn S P, Deeley R G. Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. Biol Chem 1986; 261: 5067–74
   Web of Science ®Google Scholar
• Lobo R A. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. Clin Endocrinol Metab 1991; 73: 925–30
   Google Scholar
• Wolfe B M, Huff M W. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women. Clin Invest 1993; 92: 456–61
   Google Scholar
• Nabulsi A A, Folsom A R, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069–75
   PubMed Web of Science ®Google Scholar
• Utermann G. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. Curr Opin Lipidol 1990; 1: 404–10
   Google Scholar
• Maher V MG, Brown B G. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 1995; 6: 229–35
   PubMed Web of Science ®Google Scholar
• Kraft H G, Sandholzer C, Menzel H J, Utermann G. Apolipoprotein(a) alleles determine lipoprotein(a) particle density and concentration in plasma. Arterioscler Thromb 1992; 12: 302–6
   PubMed Web of Science ®Google Scholar
• Boerwinkle E, Leffert C C, Lin J, Lackner C, Chiesa G, Hobbs H H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. Clin Invest 1992; 90: 52–60
   Google Scholar
• Soma M, Fumagalli R, Paoletti R, et al. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 1991; 337: 612
   PubMed Web of Science ®Google Scholar
• Farish E, Rolton H A, Barnes J F, Hart D M. Lipoprotein(a) concentrations in postmenopausal women taking norethisterone. BMJ 1991; 303: 694
   PubMed Web of Science ®Google Scholar
• Jenner J L, Ordovas J M, Lamon-Fava S, et al. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993; 87: 1135–41
   PubMed Web of Science ®Google Scholar
• Bruschi F, Meschia M, Soma M, Perotti D, Paoletti R, Crosignani G. Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet Gynecol 1996; 88: 950–4
   PubMed Web of Science ®Google Scholar
• Sacks F M, McPherson R, Walsh B W. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994; 154: 1106–10
   PubMedGoogle Scholar
• Haines C, Chung T, Chang A, Masarei J, Tomlinson B, Wong E. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. Arch Intern Med 1996; 156: 866–72
   PubMed Web of Science ®Google Scholar
• Kim C J, Jang H C, Cho D H, Min Y K. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler Thromb 1994; 14: 275–81
   PubMed Web of Science ®Google Scholar
• Taskinen M-R, Puolakka J, Pyorala T, et al. Hormone replacement therapy lowers plasma Lp(a) concentrations: comparison of cyclic transdermal and continuous estrogen-progestin regimens. Arterioscler Thromb Vase Biol 1996; 16: 1215–21
   PubMed Web of Science ®Google Scholar
• Tonstad S, Ose L, Gørbitz C, Djøseland O, Bard J, Fruchart J C. Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Intern Med 1995; 238: 39–47
   PubMed Web of Science ®Google Scholar
• Darling G M, Johns J A, McCloud P I, Davis S R. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 1997; 337: 595–601
   PubMed Web of Science ®Google Scholar
• Kim Jeong C, Min J K, Ryu W S, Kwak W, Ryoo U H. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Arch Intern Med 1996; 156: 1693–700
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Pines A, Stehouwer C DA, van der Mooren M J, Kenemans P. The effects of oestrogens on vessel wall and cardiac function, haemostasis and homocysteine metabolism. Eur Menopause 1996; 3: 209–18
   Google Scholar
• Manolio T A, Furberg C D, Shemanski L, et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993; 88: 2163–71
   PubMed Web of Science ®Google Scholar
• Salomaa V, Rasi V, Pekkanen J, et al. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study. Arterioscler Thromb Vase Biol 1995; 15: 1549–55
   PubMed Web of Science ®Google Scholar
• Shahar E, Folsom A R, Salomaa V V, et al. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Circulation 1996; 93: 1970–5
   PubMed Web of Science ®Google Scholar
• Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen?. Circulation 1995; 92: 5–8
   PubMed Web of Science ®Google Scholar
• Skafar D F, Xu R, Morales J, Ram J, Sowers J R. Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 1997; 82: 3913–8
   PubMed Web of Science ®Google Scholar
• St Clair R W. Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis. Curr Opin Lipidol 1997; 8: 281–6
   PubMed Web of Science ®Google Scholar
• William J K, Adams M R, Klopfenstein H S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680–7
   PubMed Web of Science ®Google Scholar
• Williams J K, Adams M R, Herrington D M, Clarkson T B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992; 20: 452–7
   PubMed Web of Science ®Google Scholar
• Reis S E, Gloth S T, Blumenthal R S, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52–60
   PubMed Web of Science ®Google Scholar
• Gilligan D M, Quyyumi A A, Cannon R O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545–51
   PubMed Web of Science ®Google Scholar
• Collins P, Rosano G MC, Sarrel P M, et al. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24–30
   PubMed Web of Science ®Google Scholar
• Rosano G MC, Sarrel P M, Poole-Wilson P A, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133–6
   PubMed Web of Science ®Google Scholar
• Lieberman E H, Gerhard M D, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936–41
   PubMed Web of Science ®Google Scholar
• Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995; 99: 119–22
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576–82
   PubMed Web of Science ®Google Scholar
• Guetta V, Quyyumi A A, Prasad A, Panza J A, Waclawiw M, Cannon R O. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997; 96: 2795–801
   PubMed Web of Science ®Google Scholar
• White R C, Darley-Usmar V, Oparil S. No role for NO in estrogen-mediated vasoprotection?. Circulation 1997; 96: 2769–71
   PubMed Web of Science ®Google Scholar
• Arnal J F, Clamens S, Pechet C, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 93: 4108–13
   PubMed Web of Science ®Google Scholar
• Keaney J F, Shwaery G T, Xu A, et al. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994; 89: 2251–9
   PubMed Web of Science ®Google Scholar
• Cooke J P, Tsao P S. Cytoprotective effects of nitric oxide. Circulation 1993; 88: 2451–4
   PubMed Web of Science ®Google Scholar
• Kim-Schultze S, McGowan K A, Hubchak S C, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996; 94: 1402–7
   PubMed Web of Science ®Google Scholar
• Venkov C D, Rankin A B, Vaughan D E. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94: 727–33
   PubMed Web of Science ®Google Scholar
• Kuiper G GMJ, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-Å. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925–30
   PubMed Web of Science ®Google Scholar
• Iafrati M D, Karas R H, Aronovitz M, et al. Estrogen inhibits the vascular injury response in estrogen receptor a-deficient mice. Nat Med 1997; 3: 545–8
   PubMed Web of Science ®Google Scholar
• Gustafsson J-A. Estrogen receptor β - getting in on the action?. Nat Med 1997; 3: 493–4
   PubMed Web of Science ®Google Scholar
• Chetkowski R J, Meldrum D R, Steingold K A, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314: 1615–20
   PubMed Web of Science ®Google Scholar
• Col N F, Eckman M H, Karas R H, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997; 277: 1140–7
   PubMed Web of Science ®Google Scholar